Dr Strosberg on Future of 177LuDotatate Therapy in Neuroendocrine Tumors

YOUR LINK HERE:

http://youtube.com/watch?v=orNz-D6nAec

Interested in learning more about the Gallium 68 DOTATATE PET? Thomas Hope, MD, a neuroendocrine cancer expert, answers questions about the Gallium 68 DOTATATE PET, including on what occasions should NET patients receive a DOTATATE PET? • This Q A is an excerpt from the Facebook Live event on September 23, 2018. Watch the full Facebook Live program here: / 1124105761111555 • Resources mentioned in this video: • NCCN Neuroendocrine Tumor Guidelines for Patients: https://www.nccn.org/patients/guideli... • NCCN Clinical Practice Guidelines for Physicians: https://www.nccn.org/professionals/ph... • Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors: https://nanets.net/images/Guidelines/... • NANETS (North American Neuroendocrine Tumor Society) Guidelines: https://nanets.net/net-guidelines-lib...

#############################

New on site